ALEXANDRIA, Va., April 2 -- United States Patent no. 12,264,198, issued on April 1, was assigned to AFFIMED GMBH (Mannheim, Germany).
"Tandem diabody for CD16A-directed NK-cell engagement" was invented by Thorsten Ross (Edingen-Neckarhausen, Germany), Ivica Fucek (Hattersheim, Germany), Kristina Ellwanger (Heidelberg, Germany), Michael Weichel (Bischofsheim, Germany), Uwe Reusch (Maikammer, Germany), Stefan Knackmuss (Planckstadt, Germany), Erich Rajkovic (Schriessheim, Germany) and Martin Treder (Heidelberg, Germany).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to a multispecific antigen-binding molecule specifically binding to CD16A and consisting of two polypeptide chains, wherein e...